Noah Charles Peeri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Noah Charles Peeri has a total of 160 co-authors. Here are the top co-authors by number of shared publications:
- Mengmeng Du
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, USA
12 shared publications - Carlotta Sacerdote
Department of Health Sciences, University of Eastern Piedmont, Via Solaroli 17, 28100 Novara, Italy
10 shared publications - Fabio Parazzini
University of Milan
10 shared publications - Fulvio Ricceri
Centre for Biostatistics, Epidemiology, and Public Health, Department of Clinical and Biological Sciences, University of Turin, Orbassano, Turin, Italy
10 shared publications - Gretchen L. Gierach
Division of Cancer Epidemiology and Genetics National Cancer Institute Rockville Maryland USA
10 shared publications - Harvey A. Risch
Department of Chronic Disease Epidemiology, Yale School of Public Health , New Haven, CT
10 shared publications
Latest Publications
- 13 November 2026
- Published by Elsevier in Addictive Behaviors
- Vol. 185, 108912
Comparing modalities (smoking vs. vaping) of nicotine and cannabis use: Differences in mental health and dependence across sociodemographic groups
- 13 November 2026
- Published by Elsevier in Addictive Behaviors
- Vol. 185, 108912
Comparing modalities (smoking vs. vaping) of nicotine and cannabis use: Differences in mental health and dependence across sociodemographic groups
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table from Sleep Duration, Chronotype, and Insomnia and the Risk of Lung Cancer: United Kingdom Biobank Cohort
Supplementary Table from Sleep Duration, Chronotype, and Insomnia and the Risk of Lung Cancer: United Kingdom Biobank Cohort
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table from Sleep Duration, Chronotype, and Insomnia and the Risk of Lung Cancer: United Kingdom Biobank Cohort
Supplementary Table from Sleep Duration, Chronotype, and Insomnia and the Risk of Lung Cancer: United Kingdom Biobank Cohort
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table from Sleep Duration, Chronotype, and Insomnia and the Risk of Lung Cancer: United Kingdom Biobank Cohort
Supplementary Table from Sleep Duration, Chronotype, and Insomnia and the Risk of Lung Cancer: United Kingdom Biobank Cohort
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table from Sleep Duration, Chronotype, and Insomnia and the Risk of Lung Cancer: United Kingdom Biobank Cohort
Supplementary Table from Sleep Duration, Chronotype, and Insomnia and the Risk of Lung Cancer: United Kingdom Biobank Cohort
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table from Sleep Duration, Chronotype, and Insomnia and the Risk of Lung Cancer: United Kingdom Biobank Cohort
Supplementary Table from Sleep Duration, Chronotype, and Insomnia and the Risk of Lung Cancer: United Kingdom Biobank Cohort
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table from Sleep Duration, Chronotype, and Insomnia and the Risk of Lung Cancer: United Kingdom Biobank Cohort
Supplementary Table from Sleep Duration, Chronotype, and Insomnia and the Risk of Lung Cancer: United Kingdom Biobank Cohort
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Data from Sleep Duration, Chronotype, and Insomnia and the Risk of Lung Cancer: United Kingdom Biobank Cohort
Background:Relationships between sleep duration, chronotype, insomnia, and lung cancer risk have not been comprehensively examined. Interrelations between sleep traits on the risk of lung cancer have not been assessed. We aimed to examine sleep traits with lung cancer risk.Methods:Participants were recruited between 2006 and 2010 and followed through November 30, 2020. We included 382,966 participants (3,664 incident lung cancer) in analysis. Cox proportional hazards models estimated HRs and 95% confidence intervals (CI) for associations between sleep duration, chronotype, and insomnia symptoms and lung cancer risk. Joint effects analyses were examined between sleep duration and three traits (chronotype, insomnia, and daytime napping). Nonlinear associations between sleep duration and lung cancer risk were assessed in restricted cubic spline analysis.Results:Longer sleep (>8 hours) was positively associated with lung cancer risk compared with normal sleep duration (7–8 hours; HR = 1.22; 95% CI, 1.10–1.36). Frequent insomnia symptoms increased the risk of lung cancer compared with never/rarely experiencing symptoms (HR = 1.16; 95% CI, 1.05–1.28). Joint effects between sleep duration and chronotype, and sleep duration and insomnia symptoms were observed. In analysis excluding participants reporting shift work at baseline, evening chronotypes (“slight,” “definite”) were at a greater risk of lung cancer compared with definite morning chronotype (HR = 1.17; 95% CI, 1.06–1.28 and HR = 1.37; 95% CI, 1.21–1.54, respectively).Conclusions:Sleep traits such as long sleep duration, frequent insomnia symptoms, and definite evening chronotype may be risk factors for lung cancer. Joint effects should be further investigated.Impact:Sleep traits may be risk factors of lung cancer.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Sleep Duration, Chronotype, and Insomnia and the Risk of Lung Cancer: United Kingdom Biobank Cohort
Background:Relationships between sleep duration, chronotype, insomnia, and lung cancer risk have not been comprehensively examined. Interrelations between sleep traits on the risk of lung cancer have not been assessed. We aimed to examine sleep traits with lung cancer risk.Methods:Participants were recruited between 2006 and 2010 and followed through November 30, 2020. We included 382,966 participants (3,664 incident lung cancer) in analysis. Cox proportional hazards models estimated HRs and 95% confidence intervals (CI) for associations between sleep duration, chronotype, and insomnia symptoms and lung cancer risk. Joint effects analyses were examined between sleep duration and three traits (chronotype, insomnia, and daytime napping). Nonlinear associations between sleep duration and lung cancer risk were assessed in restricted cubic spline analysis.Results:Longer sleep (>8 hours) was positively associated with lung cancer risk compared with normal sleep duration (7–8 hours; HR = 1.22; 95% CI, 1.10–1.36). Frequent insomnia symptoms increased the risk of lung cancer compared with never/rarely experiencing symptoms (HR = 1.16; 95% CI, 1.05–1.28). Joint effects between sleep duration and chronotype, and sleep duration and insomnia symptoms were observed. In analysis excluding participants reporting shift work at baseline, evening chronotypes (“slight,” “definite”) were at a greater risk of lung cancer compared with definite morning chronotype (HR = 1.17; 95% CI, 1.06–1.28 and HR = 1.37; 95% CI, 1.21–1.54, respectively).Conclusions:Sleep traits such as long sleep duration, frequent insomnia symptoms, and definite evening chronotype may be risk factors for lung cancer. Joint effects should be further investigated.Impact:Sleep traits may be risk factors of lung cancer.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table from Sleep Duration, Chronotype, and Insomnia and the Risk of Lung Cancer: United Kingdom Biobank Cohort
Supplementary Table from Sleep Duration, Chronotype, and Insomnia and the Risk of Lung Cancer: United Kingdom Biobank Cohort
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table from Sleep Duration, Chronotype, and Insomnia and the Risk of Lung Cancer: United Kingdom Biobank Cohort
Supplementary Table from Sleep Duration, Chronotype, and Insomnia and the Risk of Lung Cancer: United Kingdom Biobank Cohort
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table from Sleep Duration, Chronotype, and Insomnia and the Risk of Lung Cancer: United Kingdom Biobank Cohort
Supplementary Table from Sleep Duration, Chronotype, and Insomnia and the Risk of Lung Cancer: United Kingdom Biobank Cohort
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table from Sleep Duration, Chronotype, and Insomnia and the Risk of Lung Cancer: United Kingdom Biobank Cohort
Supplementary Table from Sleep Duration, Chronotype, and Insomnia and the Risk of Lung Cancer: United Kingdom Biobank Cohort
- 13 November 2025
- Published by Oxford University Press (OUP) in JNCI Cancer Spectrum
- Vol. 10 (2)
Prediagnosis diabetes, life-course body mass index and physical activity, and pancreatic cancer survival in older adults
Background: Diabetes and excess body weight are established risk factors for pancreatic ductal adenocarcinoma (PDAC); however, few studies have evaluated their association with PDAC survival. No studies have examined prediagnosis body size and physical activity across the adult life course and their impact on PDAC survival. Methods: We evaluated survival by prediagnosis self-reported diabetes and adult life course body mass index (BMI) and leisure-time physical activity from late adolescence to older age (eg, ≥50 years). We determined trajectories for BMI and leisure-time physical activity using latent class modeling. We included 2522 participants diagnosed with PDAC in the National Institutes of Health–AARP cohort between 1996 and 2018. Vital status was followed through December 31, 2019. We calculated hazard ratios (HRs) and 95% CIs for PDAC survival using multivariable Cox proportional hazard models. Significance tests were 2 sided. Results: Diabetes (vs without diabetes) was associated with reduced PDAC survival (HR = 1.36, 95% CI = 1.17 to 1.59), with similar associations by sex. Body mass index and leisure-time physical activity and their trajectories were not associated with PDAC survival. Among patients with unknown cancer stage (n = 1385), compared with low to normal BMI (≥18.5 to <22.5), obesity at age 18 years (HR = 1.56, 95% CI = 1.09 to 2.22) and high normal, overweight, and obese BMI at ages 51 to 70 years (HR = 1.33 to 1.56) were associated with reduced PDAC survival. Conclusions: Prediagnosis diabetes was associated with reduced PDAC survival. Life-course BMI and leisure-time physical activity were not associated with PDAC survival overall. Higher early-adulthood and older-adulthood BMIs were associated with poorer survival among patients with unstaged disease; however, stage is an important determinant of survival that we were unable to control for in this group.
- 13 November 2025
- Published by Oxford University Press (OUP) in JNCI Cancer Spectrum
- Vol. 10 (2)
Prediagnosis diabetes, life-course body mass index and physical activity, and pancreatic cancer survival in older adults
Background: Diabetes and excess body weight are established risk factors for pancreatic ductal adenocarcinoma (PDAC); however, few studies have evaluated their association with PDAC survival. No studies have examined prediagnosis body size and physical activity across the adult life course and their impact on PDAC survival. Methods: We evaluated survival by prediagnosis self-reported diabetes and adult life course body mass index (BMI) and leisure-time physical activity from late adolescence to older age (eg, ≥50 years). We determined trajectories for BMI and leisure-time physical activity using latent class modeling. We included 2522 participants diagnosed with PDAC in the National Institutes of Health–AARP cohort between 1996 and 2018. Vital status was followed through December 31, 2019. We calculated hazard ratios (HRs) and 95% CIs for PDAC survival using multivariable Cox proportional hazard models. Significance tests were 2 sided. Results: Diabetes (vs without diabetes) was associated with reduced PDAC survival (HR = 1.36, 95% CI = 1.17 to 1.59), with similar associations by sex. Body mass index and leisure-time physical activity and their trajectories were not associated with PDAC survival. Among patients with unknown cancer stage (n = 1385), compared with low to normal BMI (≥18.5 to <22.5), obesity at age 18 years (HR = 1.56, 95% CI = 1.09 to 2.22) and high normal, overweight, and obese BMI at ages 51 to 70 years (HR = 1.33 to 1.56) were associated with reduced PDAC survival. Conclusions: Prediagnosis diabetes was associated with reduced PDAC survival. Life-course BMI and leisure-time physical activity were not associated with PDAC survival overall. Higher early-adulthood and older-adulthood BMIs were associated with poorer survival among patients with unstaged disease; however, stage is an important determinant of survival that we were unable to control for in this group.
- 15 October 2025
- Published by Springer Nature in Current Environmental Health Reports
- Vol. 12 (1) , 1-14
Silicone Wristbands as Passive Environmental Sampling Devices in Low- and Middle-Income Countries: a Scoping Review of the Evidence
Introduction Environmental exposures have been linked to numerous health conditions. Personal sampling devices such as silicone wristbands have been deployed to better characterize these exposures. Few studies have investigated the use of silicone wristbands in low- and middle-income countries (LMICs). Understanding silicone wristbands in these settings is important since they have the potential to overcome certain logistical and cultural barriers that make biospecimen collection challenging. Thus, this scoping review aims to assess these studies by highlighting population, feasibility, accessibility, and ease of use. Methods We searched five databases for the term “silicone wristband,” resulting in 265 records. We included studies if they employed silicone wristbands as a passive sampling device and included samples from LMICs. After an abstract and full-text screening, we included 17 studies in this review. Results The studies included data from 10 LMICs that span three continents (Africa, South America, and Asia) and represent several occupations and diverse communities, both adult and pediatric. As measured through response rate, the use of silicone wristbands as passive sampling devices was widely accepted by participants. Conclusion Silicone wristbands are a suitable and effective passive sampling device in LMICs. They are easily deployed, minimally invasive, and stable in travel. Employing a standardized approach to data collection and analysis may be useful for further comparability in future studies.
- 15 October 2025
- Published by Springer Nature in Current Environmental Health Reports
- Vol. 12 (1) , 1-14
Silicone Wristbands as Passive Environmental Sampling Devices in Low- and Middle-Income Countries: a Scoping Review of the Evidence
Introduction Environmental exposures have been linked to numerous health conditions. Personal sampling devices such as silicone wristbands have been deployed to better characterize these exposures. Few studies have investigated the use of silicone wristbands in low- and middle-income countries (LMICs). Understanding silicone wristbands in these settings is important since they have the potential to overcome certain logistical and cultural barriers that make biospecimen collection challenging. Thus, this scoping review aims to assess these studies by highlighting population, feasibility, accessibility, and ease of use. Methods We searched five databases for the term “silicone wristband,” resulting in 265 records. We included studies if they employed silicone wristbands as a passive sampling device and included samples from LMICs. After an abstract and full-text screening, we included 17 studies in this review. Results The studies included data from 10 LMICs that span three continents (Africa, South America, and Asia) and represent several occupations and diverse communities, both adult and pediatric. As measured through response rate, the use of silicone wristbands as passive sampling devices was widely accepted by participants. Conclusion Silicone wristbands are a suitable and effective passive sampling device in LMICs. They are easily deployed, minimally invasive, and stable in travel. Employing a standardized approach to data collection and analysis may be useful for further comparability in future studies.
- 12 May 2025
- Published by Elsevier in Cancer Genetics
- Vol. 294-295, 171-180
Glioma grade and mortality in relation to sequence variation in the mitochondrial genome
- 12 May 2025
- Published by Elsevier in Cancer Genetics
- Vol. 294-295, 171-180
Glioma grade and mortality in relation to sequence variation in the mitochondrial genome